John Townsend - 28 Aug 2023 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Chief Financial Officer
Signature
/s/ John Townsend
Issuer symbol
UNCY
Transactions as of
28 Aug 2023
Net transactions value
$0
Form type
4
Filing time
30 Aug 2023, 16:46:27 UTC
Previous filing
23 Nov 2022
Next filing
17 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +570,329 +742% $0.000000 647,190 28 Aug 2023 Common Stock 570,329 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 142,582 of the stock options vest on March 6, 2024 and 1/36th of the remaining options vest at the end of each successive month thereafter.